Literature DB >> 17508012

Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study.

L A Ferrara1, O Cardoni, M Mancini, A Zanchetti.   

Abstract

Aims of this study were to investigate the prevalence of metabolic syndrome (MS), diagnosed according to the International Diabetes Federation (IDF) criteria and its relationship with echocardiographic parameters of cardiac structure and function. The study was performed in 707 subjects, age 45-54 years, of the Gubbio Population Study who underwent a comprehensive examination including measurement of body size, blood pressure (BP) and heart rate, 12-lead electrocardiogram, Doppler echocardiography, standardized blood and urine laboratory tests. One hundred and fifty-three subjects were found to have MS, which was more frequent among hypertensive patients than normotensive controls (36.2 vs 13.7%, P<0.001). Apart from visceral obesity present in all subjects by definition according to the IDF criteria, high levels of BP (>130/85 mm Hg) and triglycerides (>or=150 mg/dl) were the most frequently observed components of the syndrome, since their prevalence averaged 75% of those with the syndrome. Left ventricular mass (95.6+/-22 vs 86.4+/-22 g/m(2); P<0.001) and prevalence of left ventricular hypertrophy were increased in the subgroup with MS. Waist circumference, BP and blood glucose were the components of the syndrome with stronger impact on cardiac mass. An early impairment of the diastolic function was detected in this subgroup with a reduction of the early-to-late diastolic filling (0.91+/-0.17 vs 0.99+/-0.23, P<0.001). The results of the present study indicate that MS is frequent in middle-aged general population, particularly in subjects with arterial hypertension. The syndrome is associated to the increase in ventricular mass and the early impairment of diastolic function.

Entities:  

Mesh:

Year:  2007        PMID: 17508012     DOI: 10.1038/sj.jhh.1002232

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  14 in total

1.  Cohort profile: The Gubbio Population Study.

Authors:  Massimo Cirillo; Oscar Terradura-Vagnarelli; Mario Mancini; Alessandro Menotti; Alberto Zanchetti; Martino Laurenzi
Journal:  Int J Epidemiol       Date:  2013-03-29       Impact factor: 7.196

2.  Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy.

Authors:  Eberhard Wille; Jürgen Scholze; Eduardo Alegria; Claudio Ferri; Sue Langham; Warren Stevens; David Jeffries; Kerstin Uhl-Hochgraeber
Journal:  Eur J Health Econ       Date:  2010-04-20

3.  Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model.

Authors:  Jürgen Scholze; Eduardo Alegria; Claudio Ferri; Sue Langham; Warren Stevens; David Jeffries; Kerstin Uhl-Hochgraeber
Journal:  BMC Public Health       Date:  2010-09-02       Impact factor: 3.295

Review 4.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

5.  Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study.

Authors:  Pinchia Huang; Aldi T Kraja; Weihong Tang; Steven C Hunt; Kari E North; Cora E Lewis; Richard B Devereux; Giovanni de Simone; Donna K Arnett; Treva Rice; Dabeeru C Rao
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

6.  Metabolic syndrome and masked hypertension among African Americans: The Jackson Heart Study.

Authors:  Lisandro D Colantonio; D Edmund Anstey; April P Carson; Gbenga Ogedegbe; Marwah Abdalla; Mario Sims; Daichi Shimbo; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-02-06       Impact factor: 3.738

7.  Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study.

Authors:  Carlos Escobar; Vivencio Barrios; Alberto Calderón; Sara Barrios; Rocio Echarri; Josefa Navarro-Cid; Elena Ferrer; Raúl Fernandez
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

8.  Lifestyle educational program strongly increases compliance to nonpharmacologic intervention in hypertensive patients: a 2-year follow-up study.

Authors:  Aldo L Ferrara; Delia Pacioni; Valentina Di Fronzo; Barbara F Russo; Laura Staiano; Enza Speranza; Rosaria Gente; Francesco Gargiulo; Fabio Ferrara
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-11       Impact factor: 3.738

9.  Cardiac, Macro-, and Micro-Circulatory Abnormalities in Association With Individual Metabolic Syndrome Component: The Northern Shanghai Study.

Authors:  Fang Zhao; Rong Yang; Rusitanmujiang Maimaitiaili; Jiamin Tang; Song Zhao; Jing Xiong; Jiadela Teliewubai; Chen Chi; Jacques Blacher; Jue Li; Yawei Xu; Yan Jiang; Yi Zhang; Weiming Li
Journal:  Front Cardiovasc Med       Date:  2021-07-09

10.  QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network study.

Authors:  Aldi T Kraja; Pinchia Huang; Weihong Tang; Steven C Hunt; Kari E North; Cora E Lewis; Richard B Devereux; Giovanni de Simone; Donna K Arnett; Treva Rice; D C Rao
Journal:  BMC Med Genet       Date:  2008-11-27       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.